Jazz Pharmaceuticals
JAZZ
JAZZ
416 hedge funds and large institutions have $7.16B invested in Jazz Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 159 increasing their positions, 144 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
1.49% less ownership
Funds ownership: 90.42% → 88.93% (-1.5%)
3% less funds holding
Funds holding: 427 → 416 (-11)
10% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 60
Holders
416
Holding in Top 10
7
Calls
$30M
Puts
$21.7M
Top Buyers
| 1 | +$269M | |
| 2 | +$80.2M | |
| 3 | +$53.2M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$47.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.8M |
Top Sellers
| 1 | -$90.9M | |
| 2 | -$79M | |
| 3 | -$46.8M | |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
-$43.8M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$31.9M |